Clinical Trials Browser

Breast Neoplasms, Neoplasms, Prostatic Neoplasms

NCT01098955 2026-05-22

Smoking Cessation Treatment for Head & Neck Cancer Patients

Phase EARLY_PHASE1 Active not recruiting

51 enrolled

Head & Neck

Head and Neck Neoplasms, Neoplasms, Smoking Cessation

NCT04488224 2026-05-19

Nano-X IG

Phase EARLY_PHASE1 Withdrawn

Tumor-Agnostic

Neoplasms

NCT06828588 2026-05-08

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

Phase EARLY_PHASE1 Recruiting

30 enrolled

BreastGastrointestinal

Esophageal Squamous Cell Carcinoma, Breast Neoplasms, Neoplasm Metastasis, Neoplasms, Stomach Neoplasms

NCT07574346 2026-05-07

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Phase EARLY_PHASE1 Not yet recruiting

18 enrolled

Neoplasms, Recurrence

NCT07052760 2026-04-29

Imaging of Solid Tumors Using DLL3 SPECT

Phase EARLY_PHASE1 Withdrawn

Tumor-Agnostic

Neoplasms

NCT00737399 2026-04-27

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

Phase EARLY_PHASE1 Active not recruiting

14 enrolled

Gastrointestinal

Anxiety Disorders, Depression, Sleep Initiation and Maintenance Disorders, Neoplasms, Pain, Cholangiocarcinoma

NCT07493447 2026-03-25

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Phase EARLY_PHASE1 Not yet recruiting

30 enrolled

CNSEndocrine

Brain Neoplasms, Glioblastoma, Meningioma, Neoplasms, Neuroma, Acoustic, Pituitary Neoplasms

NCT05204290 2026-03-24

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

Phase EARLY_PHASE1 Terminated

1 enrolled

Neoplasms, Epidural Neoplasms

NCT04862260 2026-03-19

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Phase EARLY_PHASE1 Active not recruiting

3 enrolled

Gastrointestinal

Hyperlipoproteinemia Type II, Neoplasm Metastasis, Neoplasms, Pancreatic Neoplasms

NCT05065736 2026-03-19

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

Phase EARLY_PHASE1 Recruiting

4 enrolled

Tumor-Agnostic

Adenocarcinoma, Carcinoma, Neoplasm Metastasis, Neoplasms

NCT01804712 2026-03-12

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

Phase EARLY_PHASE1 Completed

8 enrolled 12 charts

Genitourinary

Neoplasms, Prostatic Neoplasms

NCT07420036 2026-03-03

SFB6-ZN01 PET

Phase EARLY_PHASE1 Not yet recruiting

98 enrolled

Hypersensitivity, Neoplasms

Clinical Trials

DOTA-STR-17126

Smoking Cessation Treatment for Head & Neck Cancer Patients

Nano-X IG

Pilot Study of [68Ga]Ga-ABY-025 Imaging in Patients Undergoing Treatment With HER2-targeted Therapy

IASO207 Injection in the Treatment of Relapsed/Refractory B-cell Malignancies

Imaging of Solid Tumors Using DLL3 SPECT

Anxiety and Depression Levels in Cancer Patients After Self-Application of EFT (Emotional Freedom Techniques)

Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures

Study of Combined Decompressive Spine Radiosurgery and Pembrolizumab

Cholesterol Disruption in Combination With the Standard of Care in Patients With Advanced Pancreatic Adenocarcinoma

Using a PET Imaging Agent, 18F-Clofarabine (CFA), to Measure Deoxycytidine Kinase Activity in Metastatic Cancer

Rituximab Neoadjuvant Therapy in Patients With Prostate Cancer Scheduled to Undergo Radical Prostatectomy

SFB6-ZN01 PET